Comparison

GSK8814 European Partner

Item no. TMO-T15443-500mg
Manufacturer TargetMol
CASRN 1997369-78-4
Amount 500 mg
Quantity options 100 mg 10 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1997369-78-4
Shipping Condition Cool pack
Available
Manufacturer - Targets
Epigenetic Reader Domain
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
527.61
Description
GSK8814 is a selective and ATAD2/2B bromodomain chemical probe and inhibitor (binding constant pKd=8.1 and a pKi=8.9 in BROMOscan). GSK8814 displays 500-fold selectivity for ATAD2 over BRD4 BD1. GSK8814 binds to ATAD2 and BRD4 BD1 (pIC50s: 7.3 and 4.6).
Pathways
Chromatin/Epigenetic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?